Lipid-altering drugs in development.

Drugs in R&D

Volumn 1, Issue 6, 1999, Pages 463-469

  Bays, H E ^a   Dujovne, C A ^a  

^a LOUISVILLE METABOLIC AND ATHEROSCLEROSIS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NEW DRUG;

ANIMAL; BLOOD; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; LIPID METABOLISM; METABOLISM; REVIEW;

ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; DRUGS, INVESTIGATIONAL; HUMANS; INTESTINAL ABSORPTION; LIPID METABOLISM; LIPIDS;

EID: 0033145480     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-199901060-00010     Document Type: Review

References (57)